Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
100%(2 trials)
Terminated
1(33%)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(2)
Terminated(1)

Detailed Status

Completed2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
66.7%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

terminated133%
completed267%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

Adjuvant Benefit of NMES to Supervised Exercise in Patients With IC

NCT02429310
completednot_applicable

REVITIVE for the Treatment of Patients With Venous Insufficiency

NCT02114307
terminatednot_applicable

Neuromuscular Electrical Stimulation in Patients With Critical Limb Ischaemia

NCT02634138

Clinical Trials (3)

Showing 3 of 3 trials
NCT02429310Not Applicable

Adjuvant Benefit of NMES to Supervised Exercise in Patients With IC

Completed
NCT02114307Not Applicable

REVITIVE for the Treatment of Patients With Venous Insufficiency

Completed
NCT02634138Not Applicable

Neuromuscular Electrical Stimulation in Patients With Critical Limb Ischaemia

Terminated

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3